| 1 | [SID104245542] | Active | IC50 | 0.03 | DNDI: Inhibition of Human African Trypanosomiasis (HAT), STIB 795, in vitro [AID685529, Type: other] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 104245542 | | CID | 6018993 | | Outcome | Active | | IC50 | 0.03 [uM] | | BioAssay | DNDI: Inhibition of Human African Trypanosomiasis (HAT), STIB 795, in vitro | | AID | 685529 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID104245542] | Active | IC50 | 0.2 | Cytotoxicity against human SKBR3 cells after 72 hrs by SRB assay [AID504184, Type: Literature] | |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 104245542 | | CID | 6018993 | | Outcome | Active | | IC50 | 0.2 [uM] | | BioAssay | Cytotoxicity against human SKBR3 cells after 72 hrs by SRB assay | | AID | 504184 | | BioAssay type | Literature | | Target | | | PubMed | 20728364 | | Data Table |  |
|
| 3 | [SID24781888] | Active | EC50 | 0.474 | Fluorescence Cell-Based Dose Response to Characterize Compounds Cytotoxic to RAS-Dependent BJ-TERT-LT-ST Fibroblast [AID2631, Type: confirmatory] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | EC50 | 0.474 [uM] | | BioAssay | Fluorescence Cell-Based Dose Response to Characterize Compounds Cytotoxic to RAS-Dependent BJ-TERT-LT-ST Fibroblast | | AID | 2631 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID24781888] | Active | Potency | 0.8199 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 0.8199 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID104245542] | Active | EC50 | 1.1 | Cytotoxicity against human MDA-MB-231 cells after 72 hrs by SRB assay [AID504181, Type: Literature] | |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 104245542 | | CID | 6018993 | | Outcome | Active | | EC50 | 1.1 [uM] | | BioAssay | Cytotoxicity against human MDA-MB-231 cells after 72 hrs by SRB assay | | AID | 504181 | | BioAssay type | Literature | | Target | | | PubMed | 20728364 | | Data Table |  |
|
| 6 | [SID104245542] | Active | EC50 | 1.9 | Cytotoxicity against human MDA-MB-468 cells after 72 hrs by SRB assay [AID504183, Type: Literature] | |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 104245542 | | CID | 6018993 | | Outcome | Active | | EC50 | 1.9 [uM] | | BioAssay | Cytotoxicity against human MDA-MB-468 cells after 72 hrs by SRB assay | | AID | 504183 | | BioAssay type | Literature | | Target | | | PubMed | 20728364 | | Data Table |  |
|
| 7 | [SID104245542] | Active | IC50 | 1.94 | DNDI: Cytotoxicity against human MRC-5 lung fibroblast cells. [AID685528, Type: other] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 104245542 | | CID | 6018993 | | Outcome | Active | | IC50 | 1.94 [uM] | | BioAssay | DNDI: Cytotoxicity against human MRC-5 lung fibroblast cells. | | AID | 685528 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID24781888] | Active | Potency | 2.0596 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 2.0596 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 9 | [SID104245542] | Active | IC50 | 2.12 | Cytotoxicity against human PC3 cells after 72 hrs by MTT assay [AID664955, Type: Literature] | |   View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 104245542 | | CID | 6018993 | | Outcome | Active | | IC50 | 2.12 [uM] | | BioAssay | Cytotoxicity against human PC3 cells after 72 hrs by MTT assay | | AID | 664955 | | BioAssay type | Literature | | Target | | | PubMed | 22551677 | | Data Table |  |
|
| 10 | [SID104245542] | Active | IC50 | 2.18 | Cytotoxicity against human PANC1 cells after 72 hrs by MTT assay [AID664956, Type: Literature] | |   View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 104245542 | | CID | 6018993 | | Outcome | Active | | IC50 | 2.18 [uM] | | BioAssay | Cytotoxicity against human PANC1 cells after 72 hrs by MTT assay | | AID | 664956 | | BioAssay type | Literature | | Target | | | PubMed | 22551677 | | Data Table |  |
|
| 11 | [SID104245542] | Active | IC50 | 2.35 | Cytotoxicity against human HT-29 cells after 72 hrs by MTT assay [AID664957, Type: Literature] | |   View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 104245542 | | CID | 6018993 | | Outcome | Active | | IC50 | 2.35 [uM] | | BioAssay | Cytotoxicity against human HT-29 cells after 72 hrs by MTT assay | | AID | 664957 | | BioAssay type | Literature | | Target | | | PubMed | 22551677 | | Data Table |  |
|
| 12 | [SID104245542] | Active | IC50 | 2.5 | Inhibition of NF-kappaB activation in human K562 cells [AID504182, Type: Literature] | |   View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 104245542 | | CID | 6018993 | | Outcome | Active | | IC50 | 2.5 [uM] | | BioAssay | Inhibition of NF-kappaB activation in human K562 cells | | AID | 504182 | | BioAssay type | Literature | | Target | | | PubMed | 20728364 | | Data Table |  |
|
| 13 | [SID24781888] | Active | Potency | 2.5929 | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. [AID624297, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 2.5929 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. | | AID | 624297 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 14 | [SID24781888] | Active | Potency | 3.1623 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 15 | [SID24781888] | Active | Potency | 3.1623 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 16 | [SID24781888] | Active | Potency | 3.2643 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay [AID602202, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 3.2643 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay | | AID | 602202 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 17 | [SID24781888] | Active | Potency | 3.2643 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay [AID602202, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 3.2643 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay | | AID | 602202 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 18 | [SID24781888] | Active | Potency | 3.2643 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay [AID602202, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 3.2643 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay | | AID | 602202 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 19 | [SID24781888] | Active | Potency | 3.2643 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay [AID602202, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 3.2643 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Beta-Lactamase Assay | | AID | 602202 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 20 | [SID24781888] | Active | Potency | 3.5481 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay [AID602200, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 3.5481 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay | | AID | 602200 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 21 | [SID24781888] | Active | Potency | 3.5481 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay [AID602200, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 3.5481 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay | | AID | 602200 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 22 | [SID24781888] | Active | Potency | 3.5481 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay [AID602200, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 3.5481 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay | | AID | 602200 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 23 | [SID24781888] | Active | Potency | 3.5481 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay [AID602200, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 3.5481 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation using a Fluorescein Assay | | AID | 602200 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 24 | [SID24781888] | Active | Potency | 3.6626 | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. [AID624296, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 3.6626 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. | | AID | 624296 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 25 | [SID24781888] | Active | Potency | 4.1095 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 4.1095 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID24781888] | Active | Potency | 4.14 | qHTS of small molecules that selectively kill Giardia lamblia: Hit Validation in HepG2 cytotox [AID588382, Type: confirmatory] | |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 4.14 [uM] | | BioAssay | qHTS of small molecules that selectively kill Giardia lamblia: Hit Validation in HepG2 cytotox | | AID | 588382 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 27 | [SID24781888] | Active | AC50 | 4.246 | Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_Dose_CherryPick_Activity [AID540268, Type: confirmatory] | HSP90 [Plasmodium falciparum 3D7] [gi:124809506] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | AC50 | 4.246 [uM] | | BioAssay | Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_Dose_CherryPick_Activity | | AID | 540268 | | BioAssay type | confirmatory | | Target | HSP90 [Plasmodium falciparum 3D7] [gi:124809506] | | PubMed | | | Data Table |  |
|
| 28 | [SID24781888] | Active | Potency | 4.6109 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 4.6109 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 29 | [SID24781888] | Active | Potency | 5.0119 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 5.0119 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 30 | [SID24781888] | Active | Potency | 5.0119 | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 5.0119 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding | | AID | 1460 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 31 | [SID24781888] | Active | Potency | 5.0119 | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization [AID1468, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 5.0119 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization | | AID | 1468 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 32 | [SID24781888] | Active | Potency | 5.0119 | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization [AID1468, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 5.0119 [uM] | | BioAssay | qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization | | AID | 1468 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 33 | [SID24781888] | Active | Potency | 5.0119 | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity [AID2546, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 5.0119 [uM] | | BioAssay | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2546 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 34 | [SID24781888] | Active | Potency | 5.3233 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 5.3233 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 35 | [SID24781888] | Active | Potency | 5.3233 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 5.3233 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 36 | [SID24781888] | Active | Potency | 5.3233 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 5.3233 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 37 | [SID24781888] | Active | Potency | 5.3233 | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen [AID602199, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 5.3233 [uM] | | BioAssay | qHTS for Inhibitors of the vitamin D receptor (VDR): Hit Validation in Primary Screen | | AID | 602199 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 38 | [SID24781888] | Active | Potency | 6.3096 | qHTS for inhibitors of ROR gamma transcriptional activity [AID2551, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 6.3096 [uM] | | BioAssay | qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2551 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 39 | [SID24781888] | Active | Potency | 6.3096 | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) [AID651820, Type: confirmatory] | |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 6.3096 [uM] | | BioAssay | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) | | AID | 651820 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 40 | [SID24781888] | Active | Potency | 7.0795 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 41 | [SID24781888] | Active | Potency | 7.0795 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 42 | [SID24781888] | Active | Potency | 7.0795 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 43 | [SID24781888] | Active | Potency | 7.0795 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 44 | [SID24781888] | Active | AC50 | 8.702 | HsHsp90 Counterscreen Measured in Microorganism System Using Plate Reader - 2121-02_Inhibitor_Dose_CherryPick_Activity [AID540270, Type: confirmatory] | heat shock protein HSP 90-alpha isoform 2 [Homo sapiens] [gi:154146191] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | AC50 | 8.702 [uM] | | BioAssay | HsHsp90 Counterscreen Measured in Microorganism System Using Plate Reader - 2121-02_Inhibitor_Dose_CherryPick_Activity | | AID | 540270 | | BioAssay type | confirmatory | | Target | heat shock protein HSP 90-alpha isoform 2 [Homo sapiens] [gi:154146191] | | PubMed | | | Data Table |  |
|
| 45 | [SID24781888] | Active | AC50 | 8.702 | HsHsp90 Counterscreen Measured in Microorganism System Using Plate Reader - 2121-02_Inhibitor_Dose_CherryPick_Activity [AID540270, Type: confirmatory] | heat shock protein HSP 90-alpha isoform 2 [Homo sapiens] [gi:154146191] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | AC50 | 8.702 [uM] | | BioAssay | HsHsp90 Counterscreen Measured in Microorganism System Using Plate Reader - 2121-02_Inhibitor_Dose_CherryPick_Activity | | AID | 540270 | | BioAssay type | confirmatory | | Target | heat shock protein HSP 90-alpha isoform 2 [Homo sapiens] [gi:154146191] | | PubMed | | | Data Table |  |
|
| 46 | [SID24781888] | Active | AC50 | 8.702 | HsHsp90 Counterscreen Measured in Microorganism System Using Plate Reader - 2121-02_Inhibitor_Dose_CherryPick_Activity [AID540270, Type: confirmatory] | heat shock protein HSP 90-alpha isoform 2 [Homo sapiens] [gi:154146191] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | AC50 | 8.702 [uM] | | BioAssay | HsHsp90 Counterscreen Measured in Microorganism System Using Plate Reader - 2121-02_Inhibitor_Dose_CherryPick_Activity | | AID | 540270 | | BioAssay type | confirmatory | | Target | heat shock protein HSP 90-alpha isoform 2 [Homo sapiens] [gi:154146191] | | PubMed | | | Data Table |  |
|
| 47 | [SID99494262] | Active | IC50 | 9.9 | Biochemical assay for compounds that inhibit RGS4 stimulation of Galpha1 nucleotide hydrolysis under receptor-independent steady-state conditions [AID588552, Type: confirmatory] | regulator of G-protein signaling 4 [Rattus norvegicus] [gi:8394183] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 99494262 | | CID | 6018993 | | Outcome | Active | | IC50 | 9.9 [uM] | | BioAssay | Biochemical assay for compounds that inhibit RGS4 stimulation of Galpha1 nucleotide hydrolysis under receptor-independent steady-state conditions | | AID | 588552 | | BioAssay type | confirmatory | | Target | regulator of G-protein signaling 4 [Rattus norvegicus] [gi:8394183] | | PubMed | | | Data Table |  |
|
| 48 | [SID24781888] | Active | Potency | 10 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 49 | [SID24781888] | Active | Potency | 10 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 50 | [SID24781888] | Active | IC50 | 10 | XBP1 DR counterscreen for CHOP [AID504313, Type: confirmatory] | XBP1 [Homo sapiens] [gi:47678753] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 24781888 | | CID | 6018993 | | Outcome | Active | | IC50 | 10 [uM] | | BioAssay | XBP1 DR counterscreen for CHOP | | AID | 504313 | | BioAssay type | confirmatory | | Target | XBP1 [Homo sapiens] [gi:47678753] | | PubMed | | | Data Table |  |
|